E1 Activating inhibitors
E1 activating inhibitors are compounds that target the ubiquitin-proteasome system, specifically inhibiting the activity of ubiquitin-activating enzyme E1 (UBE1). E1 enzymes are crucial for initiating the ubiquitination process, which tags proteins for degradation by the proteasome. Ubiquitination plays a pivotal role in regulating various cellular processes, including protein turnover, DNA repair, and signaling pathways. By inhibiting E1 enzymes, these inhibitors disrupt the ubiquitination cascade, leading to the accumulation of proteins that are normally degraded. This disruption can be exploited for therapeutic purposes, particularly in cancer treatment, where targeting the ubiquitin-proteasome system has shown promise in promoting apoptosis (programmed cell death) in cancer cells or sensitizing them to other treatments.
- Structure
- Product name
- CAS No.
- Molecular formula
- Inquiry
Total:1 Page 1 of 1 1
